摘要
目的探讨新型模式硬化剂注射治疗颌面部血管瘤的效果。方法我科2008年到52例颌面部血管瘤患者采用新型模式治疗为实验组,与2005年至2008年经传统模式硬化剂注射治疗颌面部血管瘤的72例患者为对照组进行比较,观察两组疗效及疗程。结果新型模式治愈41例,基本治愈10例,有效1例,无效0例,治愈率98.08%,平均疗程2次。传统模式治愈31例,基本治愈22例,有效15例,无效4例,治愈率73.61%,平均治疗4次。结论与传统模式比较,新型模式具有治愈率高、疗程短的特点,但术后疼痛较显著,与术中缝扎和区室化密切相关。
Objective To explore the new mode of treatment with stiffening agent maxillofacial hemangioma. Methods Clinical efficacy of the new mode were observed and compared with the traditional mode. Results With this new pattern 41cases have been cured, 10 cases have been basically cured,1 cases is effective and none is ineffective. The cure rate is 98.08% ,and the average course of treatment is 2 times. With the traditional pattern 31 cases 'have been cured ,22 cases have been basically cured, 15 cases are effective and 4 cases are ineffective. The cure rate is 73.61% ,and the average course of treatment is 4 times. Conclusion Compared with the traditional patterns,the new mode has a higher cure rate and a shorter process. But postoperative pain which is closely related to string suture and compartmentalization is significant.
出处
《局解手术学杂志》
2012年第6期618-619,共2页
Journal of Regional Anatomy and Operative Surgery
关键词
血管瘤
硬化剂注射
缝扎
区室化
hemangioma
hardener injection
seam pierced
compartmentalization